Skip to main content
. Author manuscript; available in PMC: 2012 Mar 1.
Published in final edited form as: Prostate. 2010 Sep 21;71(4):394–402. doi: 10.1002/pros.21253

Table 3a. Cumulative relationship between risk alleles with prostate cancer susceptibility amongst CaP patients with a “normal” PSA and DRE and healthy volunteer controls.

Cumulative risk model including all 17 risk alleles

Carrier of Variants
#
Case N=203
N= (%)
Control N=611
N= (%)
OR
(95%C.I.)
p-value
0-4 3 (1.5) 17 (2.8) --
5 12 (5.9) 43 (7.0) 1.6 (0.4-6.3) 0.52
6 18 (8.9) 103 (16.9) 1.0 (0.3-3.7) 0.99
7 32 (15.8) 133 (21.8) 1.4 (0.4-4.9) 0.64
8 35 (17.2) 144 (23.6) 1.4 (0.4-5.0) 0.62
9 43 (21.2) 98 (16.0) 2.5 (0.7-8.9) 0.16
10 32 (15.8) 58 (9.5) 3.1 (0.9-11.5) 0.08
>10 28 (13.8) 15 (2.5) 10.6 (2.7-42.0) 0.0008
*

P-trend <0.001